Abstract
Objective Multiple system atrophy (MSA) is characterized by urinary dysfunction, yet the influence of sex and gender on urinary symptoms and treatment is unclear. We sought to characterize sex and gender differences in the symptomatology, evaluation, and management of urinary dysfunction in patients with MSA.Methods Patients with MSA evaluated at our institution were reviewed and stratified by sex.Results While the prevalence of urinary symptoms was similar in male and female patients, incontinence was more common in females. Despite this, males and females underwent postvoid residual (PVR) measurement at similar rates. While catheterization rates were similar when PVR was measured, males were more than twice as likely to be catheterized than females in the absence of PVR measurement.Conclusion Urinary symptoms are common in MSA, but their presentation differs between males and females. The difference in catheterization rates may be driven by a gender disparity in referrals for PVR, which can guide treatment.
Funding Information
  • National Center for Advancing Translational Sciences (UL1 TR002377)
  • National Institutes of Health (R01 NS092625, UL1 TR000135)
  • Michael J. Fox Foundation
  • Bishop Dr. Karl Golser Foundation
  • Sturm Foundation
  • Mayo Center for Regenerative Medicine
  • Mayo Funds

This publication has 18 references indexed in Scilit: